Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

Journal:

Gastroenterology

Published:

2025-10-28

DOI:

10.1053/j.gastro.2025.08.034

Affiliations:

20

Authors:

21

Go to article

Institutions	Authors	Share
Immunovia, United States of America (USA)	4.000000	0.19
Moores Cancer Center, United States of America (USA)	2.000000	0.10
Stat One, United States of America (USA)	1.000000	0.05
Oslo University Hospital (OUS), Norway	1.000000	0.05
HonorHealth Research Institute, United States of America (USA)	1.000000	0.05
Providence Health & Services, United States of America (USA)	1.000000	0.05
McGill University Health Centre (MUHC), Canada	1.000000	0.05
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.05
Stanford University, United States of America (USA)	1.000000	0.05
University of Pittsburgh Medical Center (UPMC), United States of America (USA)	1.000000	0.05
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.05
Virginia Commonwealth University (VCU), United States of America (USA)	1.000000	0.05
University of Verona (UNIVR), Italy	1.000000	0.05
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.05
The University of Chicago (UChicago), United States of America (USA)	1.000000	0.05
Inova Fairfax Hospital, Inova Health System, United States of America (USA)	1.000000	0.05
Mount Sinai Morningside, United States of America (USA)	0.500000	0.02
Mount Sinai West, United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?